Clinical Trial

Fiber Nutritional Supplement for Management of Constipation During Pregnancy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 15, 2026 (before its estimated August 8, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the effectiveness of a daily Fiber Nutritional Supplement (Materna® Opti fiber), containing partially hydrolyzed guar gum (PHGG) and vitamins C, D, zinc, and selenium, combined with nutritional counselling, for the management of constipation during pregnancy. Constipation is a common gastrointestinal complaint in pregnancy and may negatively affect quality of life and well being. The study is designed as an open label, single arm intervention conducted in pregnant women between 13 and 27 weeks of gestation who meet the Cullen 2007 criteria for functional constipation. A total of 31 participants are planned for enrolment. Eligible participants will receive one sachet per day of the Fiber Nutritional Supplement (Materna® Opti fiber), providing approximately 5.8 g of PHGG, for a duration of 4 weeks. In addition to the investigational product, all participants will receive standardized constipation counselling at baseline, including education on constipation, lifestyle measures.
Trial Details
NCT Number NCT07588633
Lead Sponsor Société des Produits Nestlé (SPN)
Conditions Functional Constipation (FC)
Enrollment 31 participants
Start Date 2026-05-08
Primary Completion 2026-08-08 (estimated)
Study Completion 2026-10-08 (estimated)
Updated on ClinicalTrials.gov 2026-05-15